Virtual Medicinal Product (VMP)
-
Sulfasalazine 250mg/5ml oral suspension
Name Details
Current Name
Sulfasalazine 250mg/5ml oral suspension
|
Start Date
13-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
A07EC01
BNF |
Current BNF
01050100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
01050100
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
01050000
|
Start Date
02-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42298011000001106 |
29-09-2023 |
|
317430009 |
13-11-2002 |
28-09-2023 |
VMP Ingredients
VMP ingredients table
Sulfasalazine |
Based on Ingredient Substance |
|
50 mg |
1 ml |
Name
Sulfasalazine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Sulfasalazine
-
VMP
(Current) Sulfasalazine 250mg/5ml oral suspension
Virtual Medicinal Product Pack (VMPP) Information